Effects of fosfomycin on Shiga toxin-producing Escherichia coli: Quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR

Journal of Medical Microbiology

Volumn 58, Issue 7, 2009, Pages 971-973

  Ichinohe, Naoko ^a   Ohara Nemoto, Yuko ^b   Nemoto, Takayuki K ^b   Kimura, Shigenobu ^c   Ichinohe, Sadato ^d  

^a Japan   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d Ichihara Welfare and Public Health Center Chiba Prefectural Government   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFTAZIDIME; FOSFOMYCIN; KANAMYCIN; NORFLOXACIN; QUINOLONE; SHIGA TOXIN;

BACTERIAL GENE; BACTERIAL STRAIN; DRUG EFFECT; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE EXPRESSION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; FOSFOMYCIN; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; POLYMERASE CHAIN REACTION; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 67650146652     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.008573-0     Document Type: Letter

References (20)

1. Bennish, M. L., Khan, W. A., Begum, M., Bridges, E. A., Ahmed, S., Saha, D., Salam, M. A., Acheson, D. & Ryan, E. T. (2006). Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Clin Infect Dis 42, 356-362. (Pubitemid 43122310)
2. Georgopapadakou, N. H., Smith, S. A. & Sykes, R. B. (1982). Mode of action of azthreonam. Antimicrob Agents Chemother 21, 950-956.
3. Horii, T., Kobayashi, M., Sato, K., Ichiyama, S. & Ohta,M. (1998). An in-vitro study of carbapeneminduced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. J Antimicrob Chemother 41, 435-442. (Pubitemid 28167502)
4. IDSC (2007). Enterohemorrhagic Escherichia coli Infection in Japan as of April 2007, Infectious Agents Surveillance Report, vol.28, pp. 131- 132. Infectious Disease Surveillance Center, http://idsc.nih.go.jp/iasr/28/327/ tpc327.html
5. Ichinohe, N., Ohara-Nemoto, Y., Tajika, S., Kaneko, M., Tsutsumi, R., Takahashi, K., Sato, S., Ichinohe, S. & Chida, S. (1999). Effects of fosfomycin and norfloxacin on the morphological changes and expression of Shiga-like toxin in enterohemorrhagic Escherichia coli O157 :H7. J IwateMed Ass 51, 557-562 (in Japanese).
6. Ikeda, K., Ida, O., Kimoto, K., Takatorige, T., Nakanishi, N. & Tatara, K. (1999). Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157 :H7 infection. Clin Nephrol 52, 357-362.
7. Jackson, J. J. & Kropp, H. (1992). β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 165, 1033-1041.
8. Jackson, M. P., Neill, R. J., O'Brien, A. D., Holmes, R. K. & Newland, J. W. (1987). Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett 44, 109-114.
9. Kahan, F. M., Kahan, J. S., Cassidy, P. J. & Kropp, H. (1974). The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 235, 364-386.
10. Kimmitt, P. T., Harwood, C. R. & Barer, M. R. (1999). Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones. Lancet 353, 1588-1589. (Pubitemid 29219214)
11. Kimmitt, P. T., Harwood, C. R. & Barer, M. R. (2000). Toxin gene expression by Shiga toxinproducing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis 6, 458-465. (Pubitemid 30781482)
12. Matsushiro, A., Sato, K., Miyamoto, H., Yamamura, T. & Honda, T. (1999). Induction of prophages of enterohemorrhagic Escherichia coli O157 :H7 with norfloxacin. J Bacteriol 181, 2257-2260. (Pubitemid 29164982)
13. Ohara-Nemoto, Y., Kobayashi, M. & Kaneko, M. (1997). Genotype analysis of enterohemorrhagic Escherichia coli O157 :H7 strains isolated in Iwate prefecture from 1996 to February 1997. Kansenshogaku Zasshi 71, 1232-1237 (in Japanese).
14. Ohara-Nemoto, Y., Ikeda, Y., Kobayashi, M., Sasaki, M., Tajika, S. & Kimura, S. (2002). Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. Microb Pathog 33, 33-41. (Pubitemid 35034597)
15. Panos, G. Z., Betsi, G. I. & Falagas, M. E. (2006). Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157 :H7 infection? Aliment Pharmacol Ther 24, 731-742.
16. Sasaki, M., Ohara-Nemoto, Y., Tajika, S., Kobayashi, M., Yamaura, C. & Kimura, S. (2001). Antigenic characterization of a novel Streptococcus anginosus antigen that induces nitric oxide synthesis by murine peritoneal exudates cells. J Med Microbiol 50, 952-958. (Pubitemid 33010697)
17. Tarr, P. I.,Gordon, C. A. & Chandler,W. L. (2005). Shiga-toxin-producing Escherichia coli and haemolytic uremic syndrome. Lancet 365, 1073-1086. (Pubitemid 40386785)
18. Tomita, T., Ohara-Nemoto, Y., Moriyama, H., Ozawa, A., Takeda, Y. & Kikuchi, K. (2007). A novel in vitro pharmacokinetic/ pharmacodynamic model based on twocompartment open model used to simulate serum drug concentration-time profiles. Microbiol Immunol 51, 567-575. (Pubitemid 46799725)
19. Wong, C. S., Jelacic, S., Harbeeb, R. L., Watkins, S. L. & Tarr, P. I. (2000). The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157 :H7 infections. N Engl J Med 342, 1930-1936. (Pubitemid 30419087)
20. Zhang, X., McDaniel, A. D., Wolf, L. E., Keusch, G. T., Waldor, M. K. & Acheson, D. W. K. (2000). Quinolone antibiotics induce Shiga toxinencoding bacteriophages, toxin production, and death in mice. J Infect Dis 181, 664-670. (Pubitemid 30131837)